Independent quant research / Capital relevance

Independent return ideas, tested for real portfolios.

We originate systematic trading ideas, challenge them with statistical validation and realistic implementation constraints, then publish the evidence an investor needs to judge robustness, diversification potential, and mandate fit.

Research mandateDifferentiated return sources
ValidationOut-of-sample + cost-aware
Portfolio objectiveRobust diversification

The proposition

From a market hypothesis to an institution-ready research case.

A clever signal is not enough. We develop the evidence required to decide whether an idea is distinct, durable, implementable, and useful beside existing exposures.

01

Differentiated hypotheses

Independent research into market behaviour, structure, and systematic return sources that may sit outside crowded product shelves.

02

Validation dossiers

Out-of-sample evidence, regime splits, parameter sensitivity, costs, drawdowns, and explicit reasons an idea may fail.

03

Portfolio-fit analysis

Correlation, marginal risk, liquidity, capacity, and implementation questions needed to assess an idea inside an existing book.

Research-to-capital pipeline

An idea is only the beginning.

The work is designed to expose fragility early. Attractive statistics must survive competing explanations, realistic frictions, and the portfolio questions that determine whether an edge is useful to capital.

  1. 01

    Originate

    State the market mechanism, expected edge, and evidence that would reject it.

  2. 02

    Falsify

    Separate discovery from out-of-sample assessment and benchmark against simpler explanations.

  3. 03

    Stress

    Vary regimes, parameters, costs, slippage, timing, and data assumptions instead of protecting one attractive backtest.

  4. 04

    Contextualize

    Examine correlation, drawdown overlap, tail behaviour, liquidity, capacity, and operational demands.

  5. 05

    Connect

    Publish the evidence trail and open diligence with capital or research partners when the fit is credible.

Read the full validation standard

Why capital should care

Standalone performance is not portfolio value.

The objective is not another isolated backtest. It is to discover and validate return behaviour that may improve a portfolio's opportunity set, especially when conventional exposures become crowded or move together.

Diversification is treated as a measurable research question—not a label. Every serious discussion must include dependency, drawdown overlap, scale, and implementation risk.

For allocators, funds, and research teams

Bring a mandate, a portfolio gap, or a hard research question.

PRO QUANT TRADE is building a public record of independent ideas and their validation. Where the evidence and mandate align, the next step is focused diligence or research collaboration—not a retail signal sale.

Discuss mandate fit